151 related articles for article (PubMed ID: 18063535)
1. TopoTarget responds.
Parsons JL
Clin J Oncol Nurs; 2007 Dec; 11(6):789. PubMed ID: 18063535
[No Abstract] [Full Text] [Related]
2. Re: Totect: a new agent for treating anthracycline extravasation.
Ward MS
Clin J Oncol Nurs; 2007 Oct; 11(5):613; author reply 613. PubMed ID: 17962168
[No Abstract] [Full Text] [Related]
3. Totect: a new agent for treating anthracycline extravasation.
Schulmeister L
Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
[TBL] [Abstract][Full Text] [Related]
4. Dexrazoxane in anthracycline extravasation.
Langer SW; Sehested M; Jensen PB; Buter J; Giaccone G
J Clin Oncol; 2000 Aug; 18(16):3064. PubMed ID: 10944144
[No Abstract] [Full Text] [Related]
5. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R
Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560
[TBL] [Abstract][Full Text] [Related]
6. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
Frost A; Gmehling D; Azemar M; Unger C; Mross K
Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
[TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane treatment for intrathoracic anthracycline extravasation.
Schulmeister L
Onkologie; 2008 Nov; 31(11):634. PubMed ID: 19145099
[No Abstract] [Full Text] [Related]
8. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
Hasinoff BB
Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
Muthuramalingam S; Gale J; Bradbury J
Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
[TBL] [Abstract][Full Text] [Related]
10. Dexrazoxane for anthracycline extravasation.
Langer SW
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
[TBL] [Abstract][Full Text] [Related]
11. Infiltration and extravasation.
Schulmeister L
Am J Nurs; 2007 Oct; 107(10):16. PubMed ID: 17895711
[No Abstract] [Full Text] [Related]
12. Accidental anthracycline extravasation.
Held-Warmkessel J
Nursing; 2007 Dec; 37(12 Pt.1):72. PubMed ID: 18090648
[No Abstract] [Full Text] [Related]
13. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
El-Saghir N; Otrock Z; Mufarrij A; Abou-Mourad Y; Salem Z; Shamseddine A; Abbas J
Lancet Oncol; 2004 May; 5(5):320-1. PubMed ID: 15120669
[No Abstract] [Full Text] [Related]
14. Anthracycline cardiotoxicity in children.
Kremer LC; Caron HN
N Engl J Med; 2004 Jul; 351(2):120-1. PubMed ID: 15247351
[No Abstract] [Full Text] [Related]
15. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
[TBL] [Abstract][Full Text] [Related]
16. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation.
Arroyo PA; Perez RU; Feijoo MA; Hernandez MA
J Cancer Res Ther; 2010; 6(4):573-4. PubMed ID: 21358106
[TBL] [Abstract][Full Text] [Related]
17. BET 3: emergency management of anthracycline extravasation.
Drake D
Emerg Med J; 2012 Sep; 29(9):777-9. PubMed ID: 22903427
[TBL] [Abstract][Full Text] [Related]
18. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.
Venable RO; Saba CF; Endicott MM; Northrup NC
J Am Vet Med Assoc; 2012 Feb; 240(3):304-7. PubMed ID: 22256846
[TBL] [Abstract][Full Text] [Related]
19. Savene® (dexrazoxane) use in clinical practice.
Fontaine C; Noens L; Pierre P; De Grève J
Support Care Cancer; 2012 May; 20(5):1109-12. PubMed ID: 22278308
[TBL] [Abstract][Full Text] [Related]
20. Extravasation: a dreaded complication of chemotherapy.
Schrijvers DL
Ann Oncol; 2003; 14 Suppl 3():iii26-30. PubMed ID: 12821535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
